Clinical Research Directory
Browse clinical research sites, groups, and studies.
Add-on Diuretics in Acute Decompensated Heart Failure
Sponsor: Tanta University
Summary
The aim of this study is to compare the efficacy and safety of empagliflozin, acetazolamide, and metolazone as add-on therapies to loop diuretics in patients with acute decompensated heart failure.
Official title: Clinical Study Comparing Empagliflozin, Acetazolamide, and Metolazone as Add-on Therapies to Loop Diuretics in Acute Decompensated Heart Failure
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
66
Start Date
2026-02-01
Completion Date
2027-02-01
Last Updated
2026-02-04
Healthy Volunteers
No
Conditions
Interventions
empagliflozin
Empagliflozin may augment the natriuretic and aquaretic actions of loop diuretics in patients with acute decompensated heart failure and it does not typically cause electrolyte disturbances and has been shown to improve outcomes in patients with heart failure
Acetazolamide
Acetazolamide can augment the action of loop diuretics in patients with acute decompensated heart failure
metolazone
Metolazone can augment the action of loop diuretics in patients with acute decompensated heart failure
Locations (1)
Tanta university
Tanta, Egypt